HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment.

AbstractOBJECTIVE:
To analyze the effects of clomiphene citrate (CC) on cervical mucus (CM) and endometrial morphology independently of hormonal changes encountered when CC is administered for ovulation induction.
DESIGN:
Volunteers whose ovarian functions were temporarily suppressed (n = 18) by a long-acting GnRH agonist and 6 women of similar age suffering from premature ovarian failure (POF) received E2 and P. Half of the women also received CC (50 mg/d, days 2 to 6).
SETTING:
Tertiary University Institution, Hôpital A. Béclère.
PATIENTS, PARTICIPANTS:
Eighteen volunteers suffering from infertility not related to a uterine cause and 6 women of similar age suffering from POF.
MAIN OUTCOME MEASURE:
Plasma gonadotropins, E2, and P were measured at baseline to confirm that the ovaries were inactive and twice weekly during physiological E2 and P replacement. Cervical mucus was analyzed on day 14 and scored from 0 to 15. Endometrial biopsies were obtained on replacement days 20 and 24 for conventional histology and immunocytochemistry analysis of estrogen receptors and progesterone receptors (PR). Premature ovarian failure women whose results have been previously published served as controls for day 20 biopsies.
RESULTS:
Cervical mucus scored lower in women who received CC (5.5 +/- 3.2) than in controls (13.6 +/- 4.7, mean +/- SEM). On day 20, endometrial findings were similar in women treated with CC and in controls. On day 24, specimens showed a significant delay in endometrial maturation in women treated with CC. On day 24, only staining for PR selectively persisted in endometrial stroma, and no difference was observed between women who received CC and controls.
CONCLUSION:
Our results indicate that CC significantly alters CM quality and late luteal phase endometrial morphology despite physiological levels of plasma E2 and P. Hence, clinicians should monitor E2 levels when using CC, and caution should be exerted when supraphysiological levels of E2 are not present to counterbalance the effects of CC on the CM and the endometrium.
AuthorsM R Massai, D de Ziegler, V Lesobre, C Bergeron, R Frydman, P Bouchard
JournalFertility and sterility (Fertil Steril) Vol. 59 Issue 6 Pg. 1179-86 (Jun 1993) ISSN: 0015-0282 [Print] United States
PMID8495762 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Triptorelin Pamoate
  • Clomiphene
  • Gonadotropin-Releasing Hormone
  • Progesterone
  • Estradiol
  • Tryptal
Topics
  • Adult
  • Biopsy
  • Cervix Mucus (drug effects)
  • Clomiphene (pharmacology)
  • Endometrium (drug effects, pathology)
  • Estradiol (blood, pharmacology)
  • Female
  • Gonadotropin-Releasing Hormone (analogs & derivatives, pharmacology)
  • Humans
  • Ovulation Induction
  • Progesterone (blood, pharmacology)
  • Triptorelin Pamoate (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: